TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in SCIM 3 score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maximum plasma concentration of LX1606 and LX1033
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients with Early Treatment Failure (ETF)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients with Late Clinical Failure (LCF)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients with Late Parasitological Failure (LPF)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients with Adequate Clinical and Parasitological Response (ACPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in 24-hour urinary NAE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in scores on standardized tests of working memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prophylaxis of urinary tract infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Significant asymptomatic bacteriuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Blood LDL Cholesterol rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Post-prandial blood triglycerides rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cervical intraepithelial neoplasia 3 (CIN3+)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Maximum Amplitude (MA) of thromboelastography (TEG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: change of the level of brain N-acetylaspartate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: change from baseline of the total scores on Internet Addiction Test (IAT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: change of the level of brain choline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Frequencies of Cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pain Freedom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in pain from index lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Treatment Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with Discontinuations Due to Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Fertility related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: efficiency of mobile phone based routine monitoring tools
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Collection efficiency of respiratory secretions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Impact on incidence of diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Remission of infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Indicators of psychopathology
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Aneurysm Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance of extended treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Anal sphincter damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Seasonal Influenza A and/or B Cases by Age Group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Seasonal Influenza A Cases by Virus Subtypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Seasonal Influenza B Cases by Strain Lineage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 2-year Local Recurrence Rate (LRR)
Endpoint domain: Mortality/survival
Primary endpoint: Muscle Strength Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: plasma phospholipid fatty acid composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: visually evoked potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Patients With a PSA Decline of ≥50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: clinical feasibility rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate postoperative plasma lidocaine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postural Stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: confirmed virologic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Retinal arterial and venous diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal blood velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pattern ERG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse effect measures
Endpoint domain: Adverse events/effects
Primary endpoint: AUC (area under the plasma concentration-time curve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of all adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in WOMAC Physical Function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Premature termination of dialysis sessions
Endpoint domain: Adverse events/effects
Primary endpoint: Total Opioid Burden
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Health Economic Benefit
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Mean Baseline Pain score on Visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change from baseline pain score on the visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Solicited and Unsolicited Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical Laboratory Safety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence rate of rectal prolapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Recurrence rate of rectal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: PROMIS Short Form - Physical Function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: PROMIS Short Form - Pain Interference
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Development of cytopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hematological malignancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Immune regulatory and activation measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Body Image Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline in ETDRS at 4 Meters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Visual analogue Scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline in sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from baseline in general wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline in cognitive wellness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of days with any cold symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 3-month post-operative mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in Center for Epidemiologic Studies Depression Scale-Revised (CESD-R)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived helpfulness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improved outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Feasability
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ejection function of the left ventricle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Appropriate medicine adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Respiratory Index Score (RSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Lower Extremity Muscle Strength- Extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lower Extremity Muscle Strength- Flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lower Extremity Mobility-Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Extremity Mobility- Up and Go
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Extremity Mobility- Stair Climb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Extremity Mobility-Chair Rise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safest number of effective doses of MSC as measured by the MDS-UPDRS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 3-year Event-Free Survival Probability
Endpoint domain: Mortality/survival
Primary endpoint: Short-term willingness to receive HPV vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum tolerated dose (MTD) based on number of patients with dose limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: cTnT and cTnI levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in MVPA minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in tumor size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Participants Reaching an Effective Fentanyl Buccal Tablet Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in level anticoagulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Freezing of gait severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Satisfaction with telemedicine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rates of surgical success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Local Skin Responses
Endpoint domain: Adverse events/effects
Primary endpoint: Pigmentation and scarring
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Flare-ups With No New Heterotopic Ossification at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized Change in New Heterotopic Ossification Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social cognition evaluation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Direct Post-operative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Indirect Post-operative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative Detection Accuracy (NDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in physical activity level (PAL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of knowledge on self-care safety skills
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Difference in pre and post-prandial plasma GLP-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Difference in pre and post-prandial Peptide YY
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change from Baseline in the Alzheimer's Disease Composite Score (ADCOMS) at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety assessed by monitoring and recording all adverse events (AEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of all serious maternal adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of all serious infant adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of pregnancy loss
Endpoint domain: Adverse events/effects
Primary endpoint: BOLD fMRI signal contrast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: US Syncope Risk Score (The FAINT Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Canadian Syncope Risk Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Visual Analog Pain Scale (VAS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Opioid Consumption in mg
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Appearance of adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Photo irritation test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: New York Heart Association (NYHA) Class
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ARMS score difference
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: All-cause mortality plus PE and DVT
Endpoint domain: Mortality/survival
Primary endpoint: Frequency and nature of bleeding complications
Endpoint domain: Adverse events/effects
Primary endpoint: Specific Joint Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Patient Well-Being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Neuropsychological attention scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: change nocturnal systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time until last apnea episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Concentration of Fecal Elastase-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Post-transplant weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of sleep apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: quantification of amenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Cessation of New Lesion Formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Induced sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Brain lactate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Brain adenosine triphosphate (ATP) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reactive-Proactive Aggression Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Antisocial Personality Screening Device
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in areal BMD of the knee region
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Degree of agreement in triage level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of [I-124]-CPD-1028 Injection
Endpoint domain: Adverse events/effects
Primary endpoint: Resolution of VUR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of Participants With Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: X-ray assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trough Serum Concentrations (Ctrough) of IV and SC Rituximab
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of Participants With Overall Response at the End of Induction Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Left and right ventricular volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left and right ventricular mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Psychological Morbidity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of patients with active disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conditioned Pain Modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lens Power Requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in the Brief Pain Inventory (BPI) 24-hour Average Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mobility status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Genitourinary Acute Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Genitourinary Late Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Gastrointestinal Acute Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Gastrointestinal Late Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Hemodynamic responses to therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease of Overhydration, %ECW
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steroid-free clinical and endoscopic remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short Form Health Survey (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Knee injury and osteoarthritis outcome score (KOOS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of patients with vocal cord dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Plasma Viral Load Suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Visual learning and memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean percent of daily recorded adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline in Reflux Disease Symptom - Heartburn
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change From Baseline in Endoscopic Healing of Erosive Reflux Disease as Assessed by Endoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Removal of antibiotic drugs (mg/d)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Filter patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: voxels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Minimum Endogenous Glucose Production (EGP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Minimum EGP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: EGP AOC0-480
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dose limiting toxicity rate
Endpoint domain: Adverse events/effects
Primary endpoint: non-fatal grade III or greater adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of recurrent strokes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: worsening of neurological disabilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Speech Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes